Could a common hair loss drug help young cancer survivors regrow hair?
NCT ID NCT05778825
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether oral minoxidil can improve persistent hair loss in children and young adults who survived cancer. Ten participants aged 6-18 who completed cancer treatment at least a year ago will receive either minoxidil or a placebo for 4 months. Researchers will measure hair density and check for side effects, aiming to see if this treatment is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- minoxidil (oral)
- What this could lead to
- If it works, this could offer a simple treatment option for hair loss in young cancer survivors, improving their quality of life.
- What could go wrong
- This is a very small pilot study (10 participants) and early-stage (Phase 2). It may not show significant benefit, and side effects or poor adherence could limit results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may reveal hidden clues to hair loss severity
- Braids and conditioner may boost scalp cooling against chemo hair loss
- Cooling caps may keep hair on during pancreatic cancer chemo
- Exosome hair loss study halted early – what we know
- New scalp formula shows promise for hair regrowth in small study
- Cool cap could keep hair on during chemo